Corcept Therapeutics CORT Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's inventories?
- Corcept Therapeutics (CORT) reported inventories of $14.51M in Q1 2026.
- How has Corcept Therapeutics's inventories changed year-over-year?
- Corcept Therapeutics's inventories increased by 1144.1% year-over-year, from $1.17M to $14.51M.
- What is the long-term trend for Corcept Therapeutics's inventories?
- Over 5 years (2020 to 2025), Corcept Therapeutics's inventories has grown at a -7.3% compound annual growth rate (CAGR), from $16.25M to $11.09M.
- What does inventories mean?
- The total value of all goods, materials, and supplies currently held by the company for production or sale.
- How do you interpret inventories?
- Rising inventory relative to sales may signal slowing demand or overproduction, while declining inventory could suggest supply chain constraints.
- How does inventories compare across companies?
- Pharmaceutical companies often hold significant inventory to ensure consistent supply for patients.